![Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk - Journal of Cardiology Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk - Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/53a6d589-1a7f-4456-98e1-394b3a05ca06/gr1_lrg.jpg)
Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk - Journal of Cardiology
![Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig2_HTML.png)
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
![DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database - The Lancet Diabetes & Endocrinology DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/147978a2-2524-49a2-8fd1-023ac0a870dc/gr1.gif)
DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database - The Lancet Diabetes & Endocrinology
![Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram](https://www.researchgate.net/profile/Sridhara-Janardhan-3/publication/260680847/figure/fig3/AS:513088665001985@1499341278619/Fig-3-Mechanism-of-action-for-GIP-GLP-1-analogues-and-DPP4-inhibitors-in-controlling.png)
Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram
![DPP4 degrade the GLP1 and incretion, which leads to suppression of the... | Download Scientific Diagram DPP4 degrade the GLP1 and incretion, which leads to suppression of the... | Download Scientific Diagram](https://www.researchgate.net/publication/343774145/figure/fig2/AS:926657976225795@1597943886841/DPP4-degrade-the-GLP1-and-incretion-which-leads-to-suppression-of-the-insulin.png)
DPP4 degrade the GLP1 and incretion, which leads to suppression of the... | Download Scientific Diagram
![DPP-4 active site with active-site residues The catalytic pocket of... | Download Scientific Diagram DPP-4 active site with active-site residues The catalytic pocket of... | Download Scientific Diagram](https://www.researchgate.net/profile/Mark-Gorrell/publication/26837594/figure/fig3/AS:394221065392140@1471001034919/DPP-4-active-site-with-active-site-residues-The-catalytic-pocket-of-DPP-4-is-shown.png)
DPP-4 active site with active-site residues The catalytic pocket of... | Download Scientific Diagram
![Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition - ScienceDirect Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1550413118306338-fx1.jpg)
Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition - ScienceDirect
![Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig1_HTML.png)
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
![Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? | Pharmacology Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? | Pharmacology](https://www.frontiersin.org/files/Articles/569989/fphar-11-01161-HTML/image_m/fphar-11-01161-g001.jpg)